Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers

Similar Items

• Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
  od: Mackay-Wiggan, Julian, i dr.
  Izdano: (2016)
• Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata
  od: Harris, John E., i dr.
  Izdano: (2015)
• An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis
  od: Jabbari, A, i dr.
  Izdano: (2018)
• CXCR3 Blockade Inhibits T-cell Migration into the Skin and Prevents Development of Alopecia Areata
  od: Dai, Zhenpeng, i dr.
  Izdano: (2016)
• Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
  od: Jabbari, Ali, i dr.
  Izdano: (2016)